- Home
- FBRX vs SIBN Comparison
FBRX vs SIBN Comparison
Compare FBRX & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBRX | SIBN |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 899.4M | 778.8M |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | FBRX | SIBN |
|---|---|---|
| Price | $76.89 | $19.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $67.00 | $23.88 |
| AVG Volume (30 Days) | ★ 2.0M | 463.6K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.30 | 41.33 |
| EPS | N/A | ★ N/A |
| Revenue | $36,000.00 | ★ $67,301,000.00 |
| Revenue This Year | N/A | $16.95 |
| Revenue Next Year | N/A | $14.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 21.53 |
| 52 Week Low | $10.18 | $11.48 |
| 52 Week High | $77.20 | $21.89 |
Technical Indicators
Market Signals| Indicator | FBRX | SIBN |
|---|---|---|
| Relative Strength Index (RSI) | 84.38 | 63.77 |
| Support Level | $26.85 | $18.34 |
| Resistance Level | $77.20 | $19.68 |
| Average True Range (ATR) | 0.11 | 0.67 |
| MACD | -1.75 | 0.05 |
| Stochastic Oscillator | 88.64 | 79.74 |
Price Performance
Historical ComparisonAbout FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.